These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1416 related items for PubMed ID: 15122662

  • 1. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [Abstract] [Full Text] [Related]

  • 2. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1418-23. PubMed ID: 15050318
    [Abstract] [Full Text] [Related]

  • 3. Planned post-chemoradiation neck dissection: significance of radiation dose.
    Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE.
    Laryngoscope; 2006 Jan 01; 116(1):33-6. PubMed ID: 16481805
    [Abstract] [Full Text] [Related]

  • 4. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
    McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, Strome M, Carroll MA.
    Head Neck; 2003 Oct 01; 25(10):791-8. PubMed ID: 12966502
    [Abstract] [Full Text] [Related]

  • 5. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.
    Arch Otolaryngol Head Neck Surg; 2004 Jul 01; 130(7):861-7. PubMed ID: 15262764
    [Abstract] [Full Text] [Related]

  • 6. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H, Phan T, Mackinnon J, Matthews TW.
    Arch Otolaryngol Head Neck Surg; 2008 Mar 01; 134(3):257-61. PubMed ID: 18347249
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

  • 8. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA.
    J Clin Oncol; 2006 Mar 01; 24(7):1064-71. PubMed ID: 16505425
    [Abstract] [Full Text] [Related]

  • 9. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C.
    J Clin Oncol; 2004 Dec 01; 22(23):4665-73. PubMed ID: 15534360
    [Abstract] [Full Text] [Related]

  • 10. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.
    Head Neck; 2004 Jul 01; 26(7):561-72. PubMed ID: 15229898
    [Abstract] [Full Text] [Related]

  • 11. Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma.
    Igidbashian L, Fortin B, Guertin L, Soulières D, Coulombe G, Belair M, Charpentier D, Tabet JC, Nguyen-Tan PF.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):414-20. PubMed ID: 19775825
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ, Pameijer FA, de Bois J, Heemsbergen W, Balm AJ, Schornagel JH, Rasch CR.
    Head Neck; 2008 Sep 01; 30(9):1216-23. PubMed ID: 18642295
    [Abstract] [Full Text] [Related]

  • 13. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R, Pfister DG, Lee NY, Kraus DH, Shah JP, Shaha AR, Ben-Porat LS, Zelefsky MJ.
    Am J Clin Oncol; 2008 Oct 01; 31(5):465-9. PubMed ID: 18838883
    [Abstract] [Full Text] [Related]

  • 14. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 15. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 16. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
    Garden AS, Asper JA, Morrison WH, Schechter NR, Glisson BS, Kies MS, Myers JN, Ang KK.
    Cancer; 2004 Mar 15; 100(6):1171-8. PubMed ID: 15022283
    [Abstract] [Full Text] [Related]

  • 17. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH.
    Laryngoscope; 2004 Aug 15; 114(8):1438-46. PubMed ID: 15280724
    [Abstract] [Full Text] [Related]

  • 18. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
    Mukhija V, Gupta S, Jacobson AS, Eloy JA, Genden EM.
    Head Neck; 2009 Feb 15; 31(2):183-8. PubMed ID: 19031407
    [Abstract] [Full Text] [Related]

  • 19. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH.
    Cancer; 1998 Dec 01; 83(11):2270-83. PubMed ID: 9840526
    [Abstract] [Full Text] [Related]

  • 20. [Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].
    Ray-Coquard I, Bolla M, Reyt E, Brochon D, Lebeau J, Colonna M, Kolodié H, Vincent F, Chinal-Provencal J.
    Bull Cancer; 1997 Sep 01; 84(9):863-8. PubMed ID: 9435807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.